Active, not recruitingNot applicableNCT04337684

Long Term Follow-up on Menkes Disease Patients

Studying Menkes disease

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sentynl Therapeutics, Inc.
Intervention: Long Term Follow-Up(drug)
Enrollment: 50 enrolled
Eligibility: All sexes
Timeline: 2019 – 2026

Study locations (1)

Sentynl Therapeutics, Solana Beach, California, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04337684 on ClinicalTrials.gov

Other trials for Menkes disease

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1, PHASE2NCT07398508
Phase I/II Study of NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease.
Stephen G. Kaler

See all trials for Menkes disease →

← Back to all trials